The Phoenix-based company’s revenues were up 3.2 percent in the first quarter of 2020 compared to the same period a year prior. The company, which focuses on special populations and complete pharmacy benefits, also saw its first-quarter net income skyrocket to $18.3 million, compared to $400,000 in the same quarter a year prior.
The COVID-19 pandemic “presents uncertainties,” the company’s CFO, Jonathan Rubin, said in a prepared statement, but the crisis didn’t negatively affect results.
The year ahead will bring a significant transaction for Magellan Health. The company said April 30 that it entered into a definitive agreement with Molina Healthcare to divest its Magellan Complete Care business of Medicaid and Medicare plans for $850 million. The deal will bring Magellan’s managed care operations across six states under the Molina umbrella. The addition of Magellan Complete Care will grow Molina’s membership in government-sponsored health plans to more than 3.6 million across 18 states.
The deal is subject to regulatory approvals.
More articles on healthcare finance:
9 health systems with strong finances
How much federal COVID-19 aid are hospitals getting? A state-by-state analysis
Pennsylvania hospital to close, lay off 694 if sale collapses
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
